Intervention

J-tube

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions4

Lead sponsors shown2

Clinical trials

5 shown

A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsNCT01960842 · 2013-10-01

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsNCT00660387 · 2009-12-01

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's SubjectsNCT00360568 · 2009-06-01

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsNCT00357994 · 2009-01-01

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseNCT00335153 · 2008-01-01

Common conditions

Advanced Parkinson's Disease4 Dyskinesias1 Parkinson's Disease1 Severe Motor Fluctuations1

Leading sponsors

AbbVie (prior sponsor, Abbott)4 AbbVie1

Trial status mix

COMPLETED5

Phase mix

PHASE35

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.